Monday, 11 August 2014

Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Rise in the world’s aging population, increase in the number of patients living with Parkinson’s disease and growing awareness about neurological movement disorders among patients have triggered the growth of Deep Brain Stimulation devices market. Globally, neurological disorders are the main causes of mortality; these account for approximately 12% of total number of deaths. Of these, cerebrovascular diseases are responsible for 85% of deaths. Parkinson’s disease is the most common neurodegenerative movement disorder after Alzheimer’s.

Browse Deep Brain Stimulation Market Research Reports with complete TOC at

Drug therapy is the most effective treatment option available to control Parkinson’s disease in the initial stages; however, a large number of medicines are required to control the disease during the advanced stages. In late stage of the disease, Deep Brain Stimulation (DBS) surgical treatment is used to control the involuntary symptoms. DBS is an effective, clinically proven and the U.S. FDA approved advanced surgical option to treat mild to severe Parkinson’s disease. The market for DBS devices is expected to grow at a healthy rate during the forecast period of 2013 to 2019. However, high cost involvement in the surgical procedure may hamper the growth of the market. A growing burden of Parkinson’s disease on the healthcare system coupled with uncertain economic conditions in the U.S. and Europe has forced Original Equipment Manufacturers (OEMs) to develop cost-effective devices for the treatment of neurological movement disorders.

The research report on DBS devices that are used to treat Parkinson’s disease provides a detailed analysis of the global market and helps in understanding the various driving forces responsible for the growth of the market. The report discusses the DBS devices market for Parkinson’s disease based on prevalence of the disease in four regions: North America, Europe, Asia Pacific and Latin America. The market overview section of this report analyzes the market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of this market. The executive summary provides detailed insights about the report and the market in general. It also provides a market snapshot, which provides a glimpse into the present scenario of the DBS devices market. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global DBS devices market.

The global DBS devices market for Parkinson’s disease has been segmented with respect to geography. Market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the geography in terms of USD billion, considering 2012 as the base year for calculations and 2011 as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.

This is followed by the market recommendations for the DBS devices market, these include factors that may play a critical role in enhancing or boosting the market in the near future, as well as the steps that need to be taken to ensure success for manufacturers in the near future.

The report concludes with the competitive landscape and company profiles of major market players. These market players have been profiled based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Prominent players in the market that are profiled in the report include Medtronic, Inc., St. Jude Medical, Inc. and Boston Scientific Corporation. Other players that are covered in the report are Sapiens Neuro and Aleva Neurotherapeutics SA.

No comments:

Post a Comment